Reproducibility of academic preclinical translational research: lessons from the development of Hedgehog pathway inhibitors to treat cancer
Academic translational research is growing at a great pace at a time in which questions have been raised about the reproducibility of preclinical findings. The development of Hedgehog (HH) pathway inhibitors for the treatment of cancer over the past two decades offers a case study for understanding...
Main Author: | Tom Curran |
---|---|
Format: | Article |
Language: | English |
Published: |
The Royal Society
2018-08-01
|
Series: | Open Biology |
Subjects: | |
Online Access: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.180098 |
Similar Items
-
Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer
by: Daniel L. Suzman, et al.
Published: (2015-09-01) -
Investigations on Inhibitors of Hedgehog Signal Pathway: A Quantitative Structure-Activity Relationship Study
by: Zhiwei Cao, et al.
Published: (2011-05-01) -
The emerging roles of phosphatases in Hedgehog pathway
by: Long Zhao, et al.
Published: (2017-09-01) -
Methodological Rigour in Preclinical Research: Implications for its Scientific Validity and Biomedical Progress
by: Ramirez, Francisco Daniel
Published: (2019) -
Hedgehog Signaling Inhibitors as Anti-Cancer Agents in Osteosarcoma
by: Ram Mohan Ram Kumar, et al.
Published: (2015-05-01)